St. Jude Medical Sues Muddy Waters Over Allegations about the Security of its Cardiac Medical Devices | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

St. Jude Medical Sues Muddy Waters Over Allegations about the Security of its Cardiac Medical Devices

September 8, 2016
by Heather Landi
| Reprints

St. Jude Medical announced that it has filed a lawsuit against Muddy Waters Consulting LLC, Muddy Waters Capital LLC, MedSec Holdings, Ltd. and MedSec LLC on the basis of alleged false statements, false advertising, conspiracy and the related manipulation of the public markets stemming from a report alleging poor security on its cardiac medical devices.

The lawsuit is in connection to a report from short selling firm Muddy Waters released last month that noted demonstrations of cyber attacks to two of St. Jude Medical’s implantable cardiac management devices. Several days after the report was released, as reported by Healthcare Informatics, St. Jude Medical officials responded by refuting the claims by Muddy Waters and MedSec regarding the safety and security of its pacemakers and defibrillators.

The Minnesota-based global medical device manufacturer saw its shares drop after the Muddy Waters Capital report came out, according to media reports. The lawsuit is against Muddy Waters and its cybersecurity research partner MedSec as well as three individual defendants who are principals in the firms. The lawsuit was filed in the United States District Court for the District of Minnesota

In a press release, St. Jude Medical officials stated, “With this action, St. Jude Medical seeks to hold these firms and individuals accountable for their false and misleading tactics, to set the record straight about the security of its devices, and to help cardiac patients and their doctors make informed medical decisions about products that enhance and save lives every day.”

Michael T. Rousseau, president and chief executive officer at St. Jude Medical said in a prepared statement that the company was turning to the court to hold Muddy Waters and MedSec accountable for what he referred to as financially motivated scare tactics. ““We felt this lawsuit was the best course of action to make sure those looking to profit by trying to frighten patients and caregivers, and by circumventing appropriate and established channels for raising cybersecurity concerns, do not use this avenue to do so.”

St. Jude Medical officials stated, “The lawsuit filed today alleges that Muddy Waters, MedSec and the other defendants intentionally disseminated false and misleading information in order to lower the value of St. Jude Medical’s stock and to wrongfully profit from a drop in share value through a short-selling scheme. The company’s complaint refers to the Muddy Waters and MedSec repeated false allegations that began on August 25, 2016 about St. Jude Medical’s implantable cardiac devices. As further explained in the company’s complaint, the defendants’ financially self-interested attempts to mislead doctors and patients demonstrate a total disregard for the patients whose lives depend on their cardiac management devices.”

According to St. Jude Medical, the complaint also cites a third-party assessment of the Muddy Waters Report by University of Michigan researchers “who found that ‘the evidence does not support their conclusions… [the University of Michigan researchers] were able to generate the reported conditions without there being a security issue.’”

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.